PG13: Modern Management of Polycystic Ovary Syndrome in Adolescents
Time:8:15 am - 5:00 pm
Location:Room 255 - Boston Convention and Exhibition Center
Jennifer E. Dietrich, M.S., M.Sc. (Chair), Baylor College of Medicine
Beth W. Rackow, M.D., Columbia University
Samantha M. Pfeifer, M.D., University of Pennsylvania Medical School
Staci Pollack, M.D., Albert Einstein College of Medicine
Developed in Cooperation with the Pediatric and Adolescent Gynecology Special Interest Group
NEEDS ASSESSMENT AND COURSE DESCRIPTION
Polycystic ovary syndrome (PCOS) affects an estimate 5-7% of women of reproductive age. True estimates are difficult to define in adolescents, but have been postulated to be higher. Because PCOS is associated with comorbidities such as diabetes mellitus type II, hypertension, non-alcoholic steatosis and obesity as well as other health problems, it is critical to establish an early diagnosis to avoid significant health problems later in life
This live course designed for clinicians who care fore adolescent females will cover current scientific papers and new areas of research that focus on adolescent needs and screening. Through a lecture/audience participation format, participants will discuss early warning signs such as precocious adrenarche that help providers determine the best time to screen adolescents for PCOS, which should result in improved patient lifelong health.
At the conclusion of this course, participants should be able to:
- Confidently perform an evaluation for PCOS on an adolescent female.
- Differentiate adult criteria from adolescent criteria in making the diagnosis of PCOS.
- Detect early warning signs indicating a possible diagnosis of PCOS in the adolescent and evaluate the need for early screening and early intervention.
- Discuss the available treatment options for adolescents with PCOS.